Literature DB >> 2839719

Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains.

F Sedarati1, R T Javier, J G Stevens.   

Abstract

We previously reported that simultaneous inoculation of mice on abraded rear footpads with two nonneuroinvasive viruses (herpes simplex virus type 1 ANG and KOS) resulted in the deaths of 62% of the animals (R. T. Javier, F. Sedarati, and J. G. Stevens, Science 234:746-748, 1986). In the current study, to better understand the events responsible for the pathogenesis of this virus mixture, we investigated replicative capacity and spread of the virus mixture within specific tissues. We found that, compared with neuroinvasiveness of ANG or KOS alone, neuroinvasiveness of the virus mixture related to significantly increased amounts of the virus within spinal cords and brains of the mice. This finding indicates that ANG and KOS have defects in their capacities to spread and replicate within spinal cords. We also examined whether the increased neuroinvasiveness of the virus mixture related to complementation between viruses in tissues of the nervous system, generation and selection of neuroinvasive recombinants, or both. It was found that, although neuroinvasive recombinant viruses could be detected in the spinal cords of the infected animals, most of the viruses (both recombinants and nonrecombinants) isolated from all tissues tested were nonneuroinvasive (i.e., no mice died as a result of footpad infection with high doses of such plaque-purified isolates). As a result of these findings, we propose that the virulence of the virus mixture is a consequence of the complementation as well as the generation and selection of neuroinvasive recombinants in spinal cords of these mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839719      PMCID: PMC253744          DOI: 10.1128/JVI.62.8.3037-3039.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  7 in total

1.  Biological basis for virulence of three strains of herpes simplex virus type 1.

Authors:  F Sedarati; J G Stevens
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

2.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

3.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

4.  Experimental infection of inbred mice with herpes simplex virus. V. Investigations with a virus strain non-lethal after peripheral infection.

Authors:  G Kümel; H Kirchner; R Zawatzky; H Engler; C H Schröder; H C Kaerner
Journal:  J Gen Virol       Date:  1982-12       Impact factor: 3.891

5.  Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Authors:  R D Dix; R R McKendall; J R Baringer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Two avirulent herpes simplex viruses generate lethal recombinants in vivo.

Authors:  R T Javier; F Sedarati; J G Stevens
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

7.  Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS.

Authors:  R L Thompson; M L Cook; G B Devi-Rao; E K Wagner; J G Stevens
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

  7 in total
  14 in total

1.  Effects of potyvirus effective population size in inoculated leaves on viral accumulation and the onset of symptoms.

Authors:  Mark P Zwart; José-Antonio Daròs; Santiago F Elena
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

2.  Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.

Authors:  Y Nishiyama; H Kimura; T Daikoku
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Using HSV-1 genome phylogenetics to track past human migrations.

Authors:  Aaron W Kolb; Cécile Ané; Curtis R Brandt
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

4.  Mixed genotype transmission bodies and virions contribute to the maintenance of diversity in an insect virus.

Authors:  Gabriel Clavijo; Trevor Williams; Delia Muñoz; Primitivo Caballero; Miguel López-Ferber
Journal:  Proc Biol Sci       Date:  2009-11-25       Impact factor: 5.349

5.  Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host.

Authors:  Luka Cicin-Sain; Jürgen Podlech; Martin Messerle; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.

Authors:  R L Kintner; R W Allan; C R Brandt
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice.

Authors:  P Sundaresan; W D Hunter; R L Martuza; S D Rabkin
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons.

Authors:  F Sedarati; K M Izumi; E K Wagner; J G Stevens
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness.

Authors:  S A Yuhasz; J G Stevens
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Mixed infections of Pepino mosaic virus strains modulate the evolutionary dynamics of this emergent virus.

Authors:  P Gómez; R N Sempere; S F Elena; M A Aranda
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.